Atom | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Due Dates: November 17, 2025 (final application deadline)

Funding Amounts: Award amount not specified; funding supports multi-stage small molecule drug discovery and development projects by small businesses.

Summary: Supports small businesses in advancing small molecule drug discovery and development for nervous system disorders, with access to NIH resources and expertise.

Key Information: Eligible only to U.S. small businesses; foreign entities cannot apply.

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Sign in to see full grant listing